Get started
Autolus Therapeutics plcAutolus Therapeutics plcAutolus Therapeutics plc

Autolus Therapeutics plc

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

AUTL trade ideas

AUTL - Probable Accumulation With Pump PotentialAUTL is a big deal in medical innovation. If their lead cancer product "Obe-cel" gets approved then it may pump. On the chart this area is likely to be an accumulation unfolding. We've has a 3 wave move up as we've seen many times in crypto already. A 3 wave move up is corrective and so it is likely that we'll even see a Golden Window retracement $2.23 - $2.89. But also possible is that we may see a slightly lower low ST Secondary Test. We'll see how it develops and if more clues arrive. The 3 wave pattern was a 1:1.618 extension GW. This is a strong ratio and this may at least be a clue that this is an accumulation, not a continuation pattern. And it increases the odds that it bottoms in the retracement GW rather than a Secondary Test... But it could really be either outcome. So this trade is buying an area with a long term view. My first buy point is within the Golden Window $2.23 - $2.89. And i'll consider that a second buy point below the low @ $1.60 may be possible. I'll look for more clues as it develops 😼. Not advice.
NASDAQ:AUTLLong
by dRends35
3
AUTL Is this a pump and dump?AUTL on the one-hour chart had a spontaneous parabolic move without a catalyst as best as I can tell. Earnings ten days ago were decent but nothing special. AUTL as a biotech firm is losing cash just not as much as analysts predicted. In the parabolic move very few shares were traded between $2.00 and $2.40 as per the volume profile Overall a massive volume occurred compared with the entire year although there was a bit in the runup to earnings. I suspect a pump and dump and think it might be worth playing. Insiders could be manipulating the shares and acting as a team. The zero-lag MACD suggests that the top has been reached. I believe that insiders will be selling quickly and short sellers will be joining in. I will be one of the latter. Retail buyers could be stuck bag holding if caught by surprise. Once price drops to $4.00 the bearish momentum will kick in due to the volume void on the profile. Accordingly, I will buy a group of call options when AUTL hits $4.05 set a stop loss and await the flush back down to $2.00. If things go well this will be over a 100% return on investment and 300% return on risk in one day. The contracts for 6/16 ( $5.00) are about $250 with about 25% spread between the bid and ask.
NASDAQ:AUTLShort
by AwesomeAvani
$AUTL Trend Reversal - LONG8M Float 8% Short $386 M market cap Offering complete Feb 12 Looks like AUTL may be breaking out of it's downtrend soon. I picked up a position on Feb 12. Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Autolus Therapeutics today and set a price target of $18.00. The company’s shares closed last Friday at $7.29. According to TipRanks.com, Goldstein is a 5-star analyst with an average return of 19.4% and a 43.5% success rate. Goldstein covers the Healthcare sector, focusing on stocks such as Adaptimmune Therapeutics, Iovance Biotherapeutics, and Corvus Pharmaceuticals. Currently, the analyst consensus on Autolus Therapeutics is a Strong Buy with an average price target of $16.20. (source: www.smarteranalyst.com)
NASDAQ:AUTLLong
by runNgun
2